ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 175 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,740,951 | +0.1% | 132,986 | +29.6% | 0.00% | 0.0% |
| Q2 2023 | $4,735,014 | +71.9% | 102,645 | +49.5% | 0.00% | +33.3% |
| Q1 2023 | $2,753,908 | +49.4% | 68,676 | +72.6% | 0.00% | +50.0% |
| Q4 2022 | $1,843,286 | -12.9% | 39,786 | +114.1% | 0.00% | 0.0% |
| Q1 2021 | $2,116,000 | -37.9% | 18,585 | -24.5% | 0.00% | -50.0% |
| Q4 2020 | $3,409,000 | +53.6% | 24,627 | -8.8% | 0.00% | +33.3% |
| Q3 2020 | $2,219,000 | +41.9% | 27,000 | +35.0% | 0.00% | +50.0% |
| Q2 2020 | $1,564,000 | +60.1% | 20,000 | -9.1% | 0.00% | +100.0% |
| Q1 2020 | $977,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |